Ownership history in HAP Trading, LLC · 37 quarters on record
This page tracks every 13F SEC filing in which HAP Trading, LLC reported a position in BIOMARIN PHARMACEUTICAL INC (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | REDUCED | 11,634 | -21,266 | -64.6% | 0.09% | $822.4M | $70.69 |
| 2025 Q1 | ADDED | 32,900 | +19,055 | +137.6% | 0.06% | $598.1M | $70.69 |
| 2024 Q4 | REDUCED | 13,845 | -18,855 | -57.7% | 0.08% | $910.0M | $65.73 |
| 2024 Q4 | ADDED | 32,700 | +1,000 | +3.2% | 0.07% | $767.8M | $65.73 |
| 2024 Q3 | ADDED | 31,700 | +8,934 | +39.2% | 0.07% | $625.0M | $70.29 |
| 2024 Q3 | REDUCED | 22,766 | -23,234 | -50.5% | 0.18% | $1.60B | $70.29 |
| 2024 Q2 | ADDED | 46,000 | +10,507 | +29.6% | 0.00% | $38.6M | $82.33 |
| 2024 Q2 | ADDED | 35,493 | +24,893 | +234.8% | 0.35% | $2.92B | $82.33 |
| 2023 Q2 | REDUCED | 10,600 | -9,149 | -46.3% | 0.01% | $38.5M | $86.68 |
| 2021 Q4 | ADDED | 19,749 | +3,246 | +19.7% | 0.05% | $1.7M | $88.35 |
As of 2025 Q4 — sorted by position size